Crinetics Pharmaceuticals, Inc. Retained Earnings
Crinetics Pharmaceuticals, Inc. (CRNX) had Retained Earnings of -$1.67 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-03
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.67B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.55B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.42B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.29B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$1.67B 10-Q · filed 2026-08-03 |
| 2026-03-31 | -$1.55B 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$1.42B 10-Q · filed 2026-08-03 |
| 2025-09-30 | -$1.29B 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$1.16B 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$1.05B 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$952.11M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$871.51M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$794.69M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$720.63M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$653.70M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$593.61M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$536.15M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$485.17M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$439.17M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$394.18M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$352.26M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$309.88M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$275.25M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$244.46M 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$216.61M 10-Q · filed 2021-08-10 |
| 2021-03-31 | -$190.51M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$167.61M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$145.97M 10-Q · filed 2020-11-06 |
| 2020-06-30 | -$127.65M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$111.16M 10-Q · filed 2020-05-08 |
| 2019-12-31 | -$93.80M 10-K · filed 2021-03-30 |
| 2019-09-30 | -$79.25M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$64.82M 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$52.40M 10-Q · filed 2019-05-13 |
| 2018-12-31 | -$43.38M 10-K · filed 2020-03-09 |
| 2018-09-30 | -$34.88M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$27.30M 10-Q · filed 2018-08-30 |
| 2017-12-31 | -$16.27M 10-K · filed 2019-03-13 |